Articles tagged with "GW Pharmaceuticals"
5 total articles - Page 1 of 1
DEA loosens rules on prescription CBD drug Epidiolex
David Downs - Published on April 6, 2020Read morePrescription CBD tincture Epidiolex is coming to more patients. Cost: $32,500 per year.
What’s Next for Epidiolex Maker GW Pharmaceuticals
Ben Adlin - Published on June 28, 2018Read moreLeafly spoke with VP Stephen Schultz about the significance of FDA approval, when Epidiolex might become available to patients, and what’s coming next from the drugmaker.
Spicer Sends Cannabis Stocks Into Trump Slump
Lisa Rough - Published on February 27, 2017Read moreThe repercussions from Trump administration comments continue to echo through the cannabis industry.
![]()
How GW Pharma Could Use US Patents to Shape the Future of Medical Cannabis
Bruce Barcott - Published on March 16, 2016Read moreAfter its success with epilepsy drug Epidiolex, the British company is patenting drugs to treat cancer, epilepsy, diabetes — even constipation.
![]()
3 Facts About Cannabis, Obesity, and Diabetes
Anna Wilcox - Published on December 12, 2013Read moreNew studies are finding that cannabis may be key to controlling diabetes. Multiple studies have found a correlation between cannabis, weight control, and potential diabetes treatments.
